Supply Chain Intelligence

Raphael Pharmaceutical Inc. Supply Chain

RAPH supply chain intelligence for Raphael Pharmaceutical Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

RAPH ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
1Customers
3Debt Items
20Related Chains

Raphael Pharmaceutical Inc. Suppliers

TickerNameConfidenceEvidence
RAMBAM RAMBAM 92% On July 17, 2019, we entered into a sponsored Research Agreement with Rambam, pursuant to which the Company agreed to fund a research project, to be performed by Rambam
WOLC WOLC 92% Wolc will be the exclusive supplier of any approved pharmaceutical drug products of the Company in Israel.
ORANY ORANY 72% ct to the receipt of regulatory approval to commercialize our pharmaceutical product candidates, our goal is to distribute our approved formulas to good manufacturing practice, or GMP, approved medic…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: ct to the receipt of regulatory a…

Raphael Pharmaceutical Inc. Customers

TickerNameConfidenceEvidence
CLM Cornerstone Strategic Investment Fund, Inc. 80% Reciprocal relationship from CLM graph: Alias reverse search [Cornerstone]: RAPH 10-K (2026-03-31) mentions 'Cornerstone' in customer context. Excerpt: various cannabinoid receptors and determine the…

Raphael Pharmaceutical Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RAPH-DEBT-12050 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
RAPH-DEBT-12049 Warrants outstanding: 1000000 90% xbrl warrant detail from xbrl 2025-12-31.
RAPH-DEBT Debt stack $37,000 90% Market cache reports total debt of $37,000.

Raphael Pharmaceutical Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Raphael Pharmaceutical Inc..

Raphael Pharmaceutical Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Raphael Pharmaceutical Inc..

Raphael Pharmaceutical Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['supplier']
AMZE Amaze Holdings, Inc. 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
BLTE Belite Bio, Inc 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
AUMN Golden Minerals Company 50.00 2
View RAPH supply chain intel →

Explore the full interactive supply chain map for Raphael Pharmaceutical Inc..

Open RAPH supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map